Department of Neurobiology and Center for Glial Biology in Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Neuroscience. 2010 Jul 28;168(4):971-81. doi: 10.1016/j.neuroscience.2009.09.020. Epub 2009 Sep 15.
Glial-derived tumors, gliomas, are highly invasive cancers that invade normal brain through the extracellular space. To navigate the tortuous extracellular spaces, cells undergo dynamic changes in cell volume, which entails water flux across the membrane through aquaporins (AQPs). Two members of this family, AQP1 and AQP4 are highly expressed in primary brain tumor biopsies and both have a consensus phosphorylation site for protein kinase C (PKC), which is a known regulator of glioma cell invasion. AQP4 colocalizes with PKC to the leading edge of invading processes and clustered with chloride channel (ClC2) and K(+)-Cl(-) cotransporter 1 (KCC1), believed to provide the pathways for Cl(-) and K(+) secretion to accomplish volume changes. Using D54MG glioma cells stably transfected with either AQP1 or AQP4, we show that PKC activity regulates water permeability through phosphorylation of AQP4. Activation of PKC with either phorbol 12-myristate 13-acetate or thrombin enhanced AQP4 phosphorylation, reduced water permeability and significantly decreased cell invasion. Conversely, inhibition of PKC activity with chelerythrine reduced AQP4 phosphorylation, enhanced water permeability and significantly enhanced tumor invasion. PKC regulation of AQP4 was lost after mutational inactivation of the consensus PKC phosphorylation site S180A. Interestingly, AQP1 expressing glioma cells, by contrast, were completely unaffected by changes in PKC activity. To demonstrate a role for AQPs in glioma invasion in vivo, cells selectively expressing AQP1, AQP4 or the mutated S180A-AQP4 were implanted intracranially into SCID mice. AQP4 expressing glioma cells showed significantly reduced invasion compared to AQP1 and S180 expressing tumors as determined by quantitative stereology, consistent with a differential role for AQP1 and AQP4 in this process.
胶质源性肿瘤,即神经胶质瘤,是高度侵袭性的癌症,通过细胞外空间侵犯正常大脑。为了在曲折的细胞外空间中导航,细胞的细胞体积会发生动态变化,这需要水通过水通道蛋白 (AQP) 跨膜流动。该家族的两个成员,AQP1 和 AQP4 在原发性脑肿瘤活检中高度表达,并且都有蛋白激酶 C (PKC) 的一致磷酸化位点,PKC 是已知的神经胶质瘤细胞侵袭的调节因子。AQP4 与 PKC 共定位到侵袭过程的前沿,并与氯离子通道 (ClC2) 和 K(+)-Cl(-) 共转运蛋白 1 (KCC1) 聚集在一起,据信这些蛋白为 Cl(-) 和 K(+) 的分泌提供途径以完成体积变化。使用稳定转染 AQP1 或 AQP4 的 D54MG 神经胶质瘤细胞,我们表明 PKC 活性通过 AQP4 的磷酸化调节水通透性。用佛波醇 12-肉豆蔻酸 13-醋酸酯或凝血酶激活 PKC 会增强 AQP4 的磷酸化,降低水通透性,并显著降低细胞侵袭。相反,用 Chelerythrine 抑制 PKC 活性会降低 AQP4 的磷酸化,增强水通透性,并显著增强肿瘤侵袭。当 S180A 磷酸化位点的共识 PKC 磷酸化失活时,PKC 对 AQP4 的调节作用就会丢失。有趣的是,表达 AQP1 的神经胶质瘤细胞与 PKC 活性的变化完全无关。为了证明 AQPs 在体内神经胶质瘤侵袭中的作用,将选择性表达 AQP1、AQP4 或突变的 S180A-AQP4 的细胞颅内植入 SCID 小鼠。通过定量体视学,与表达 AQP1 和 S180 的肿瘤相比,表达 AQP4 的神经胶质瘤细胞的侵袭明显减少,这与 AQP1 和 AQP4 在该过程中的不同作用一致。